Clinical Trials Directory

Trials / Completed

CompletedNCT03292887

Hunter Outcome Survey (HOS)

Hunter Outcome Survey: A Global, Multi-Center, Long-Term, Observational Registry of Patients With Hunter Syndrome (Mucopolysaccharidosis Type II, MPS II)

Status
Completed
Phase
Study type
Observational
Enrollment
1,443 (actual)
Sponsor
Shire · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to collect data that will increase understanding of Hunter syndrome. The data from HOS may provide guidance to healthcare professionals about disease treatment options.

Conditions

Timeline

Start date
2005-10-03
Primary completion
2023-02-16
Completion
2023-02-16
First posted
2017-09-26
Last updated
2024-10-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03292887. Inclusion in this directory is not an endorsement.

Hunter Outcome Survey (HOS) (NCT03292887) · Clinical Trials Directory